Non-infective left ventricular lead complications requiring re-intervention following cardiac resynchronization therapy: prevalence, causes and outcomes.
Christoffer Tobias WittMarie Jennyfer Ng Kam ChuenMads Brix KronborgJens KristensenChristian GerdesJens Cosedis NielsenPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2021)
A small but significant proportion of patients required LV lead re-intervention for complications following de novo implant. Lead displacement accounted for half of the re-interventions. Re-intervention was associated with a higher complication rate, but 92% of these patients had functional LV leads at the end of follow-up.
Keyphrases
- left ventricular
- end stage renal disease
- randomized controlled trial
- cardiac resynchronization therapy
- newly diagnosed
- chronic kidney disease
- ejection fraction
- heart failure
- risk factors
- peritoneal dialysis
- type diabetes
- prognostic factors
- coronary artery disease
- patient reported outcomes
- metabolic syndrome
- mitral valve
- insulin resistance
- percutaneous coronary intervention